{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T14:20:10Z","timestamp":1793974810754,"version":"4.8.0"},"reference-count":39,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2009,11,24]],"date-time":"2009-11-24T00:00:00Z","timestamp":1259020800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[2010,3]]},"abstract":"<jats:p> <jats:bold>WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT<\/jats:bold> <\/jats:p><jats:p>\u2022\u2003Dilated cardiomyopathy is a frequent disease, responsible for 40\u201350% of cases of heart failure.<\/jats:p><jats:p>\u2022\u2003Several aetiologies have been reported: idiopathic, familial\/genetic, viral and\/or immune but also toxic agents (alcohol, cobalt, carbon monoxide, lead, cocaine, mercury or drugs).<\/jats:p><jats:p>\u2022\u2003Among drugs, anthracyclines are well known to induce such an adverse drug reaction.<\/jats:p><jats:p> <jats:bold>WHAT THIS STUDY ADDS<\/jats:bold> <\/jats:p><jats:p>\u2022\u2003This study describes an association with already suspected drugs (anthracyclines, antiretrovirals).<\/jats:p><jats:p>\u2022\u2003It also found a signal with other drugs (antipsychotics, lithium, antidepressants, retinoids).<\/jats:p><jats:p>\u2022\u2003This pharmacovigilance signal should be confirmed by further prospective studies.<\/jats:p><jats:p><jats:bold>AIMS<\/jats:bold> To evaluate putative associations between drugs and dilated cardiomyopathy.<\/jats:p><jats:p><jats:bold>METHODS<\/jats:bold> We used the case\/noncase method in the French PharmacoVigilance Database (FPVD). Cases were all the observations with dilated cardiomyopathy registered into the FPVD between 1 January 1990 and 30 June 2007. Noncases were all other reports other than those studied. Anthracyclines were used as positive controls. Data were expressed as reporting odds ratio (ROR) with their 95% confidence intervals.<\/jats:p><jats:p><jats:bold>RESULTS<\/jats:bold> Out of the 258\u2003729 adverse drug reaction (ADR) reports recorded in the FPVD between 1 January 1990 and 30 June 2007, 47 (22 men, mean age 49 years) were defined as dilated cardiomyopathy. In these 47 patients, 67 drugs were \u2018suspect\u2019. A significant ROR was found with cytotoxic (epirubicin, mitoxantrone, cyclophosphamide, gemcitabine, fluorouracil) and antiretroviral (lamividune, zidovudine, abacavir) but also with isotretinoin, prednisone, appetite suppressant (clobenzorex) and psychotropic [antipsychotic (clozapine, olanzapine), lithium, antidepressant (clomipramine, amitriptyline, fluvoxamine)] drugs.<\/jats:p><jats:p><jats:bold>CONCLUSIONS<\/jats:bold> The present study describes an association between some drugs and reports of dilated cardiomyopathies. This relationship involves not only some already suspected drugs (anthracyclines, antiretrovirals), but also other drugs (antipsychotics, lithium, antidepressants, retinoids) less known to induce such an ADR. Despite the mandatory limits of this kind of study (underreporting, confounding factors\u2003.\u2003.\u2003.), these data represent a pharmacovigilance signal and could contribute to establish further prospective studies in order to confirm such signals.<\/jats:p>","DOI":"10.1111\/j.1365-2125.2009.03596.x","type":"journal-article","created":{"date-parts":[[2009,11,24]],"date-time":"2009-11-24T11:05:44Z","timestamp":1259060744000},"page":"287-294","source":"Crossref","is-referenced-by-count":43,"title":["Drugs and dilated cardiomyopathies: a case\/noncase study in the French PharmacoVigilance Database"],"prefix":"10.1111","volume":"69","author":[{"given":"Guillaume","family":"Montastruc","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Favreliere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Sommet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryse","family":"Lapeyre\u2010Mestre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie\u2010Christine","family":"Perault\u2010Pochat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean\u2010Louis","family":"Montastruc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"French Association of Regional PharmacoVigilance Centres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,2,10]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehm342"},{"key":"e_1_2_7_3_2","first-page":"2589","volume-title":"Comprehensive Cardiovascular Medicine","author":"Rodkey SM","year":"1998"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.47.5.1022"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.44.6.672"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199412083312307"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200022040-00002"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1997.00652.x"},{"key":"e_1_2_7_9_2","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1046\/j.1365-2125.1997.00615.x","article-title":"Reports of hypoglycaemia associated with the use of ACE inhibitors and other drugs: a case\/non\u2010case study in the French pharmacovigilance system database","volume":"44","author":"Moore N","year":"1998","journal-title":"Br J Clin Pharmacol"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200225060-00010"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(92)90158-J"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-004-0813-5"},{"key":"e_1_2_7_13_2","first-page":"557","article-title":"French PharmacoVigilance Database system: examples of utilization","volume":"50","author":"Moore N","year":"1995","journal-title":"Therapie"},{"key":"e_1_2_7_14_2","volume-title":"International Monitoring of Adverse Reactions to Drugs: Adverse Reaction Terminology","author":"WHO","year":"1992"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02799-9"},{"key":"e_1_2_7_16_2","first-page":"301","volume-title":"Stephens' Detection of New Adverse Drug Reactions","author":"Ewans SJW","year":"2004"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1157"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2003.01968.x"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200730090-00005"},{"key":"e_1_2_7_20_2","first-page":"145","article-title":"Late cardiotoxicity of anthracyclines","volume":"8","year":"1999","journal-title":"Prescrire Int"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(99)00006-6"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200022040-00002"},{"key":"e_1_2_7_23_2","first-page":"47","article-title":"Clozapine\u2010associated myocarditis: a review of 116 cases of suspected myocarditis associated with the use of clozapine in Australia during 1993\u20132003","volume":"30","author":"Maas SJ","year":"2007","journal-title":"Drug Saf"},{"key":"e_1_2_7_24_2","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1097\/00007611-198311000-00039","article-title":"Cardiomyopathy associated with tricyclic antidepressants","volume":"76","author":"Howland JS","year":"1983","journal-title":"South Med J"},{"key":"e_1_2_7_25_2","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1176\/ajp.148.11.1601a","article-title":"Tricyclics and heart failure","volume":"148","author":"Dallack GW","year":"1991","journal-title":"Am J Psychiatry"},{"key":"e_1_2_7_26_2","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/0167-5273(94)02231-7","article-title":"Reversal of dilated cardiomyopathy after chronic antidepressant drug withdrawal","volume":"48","author":"Marti V","year":"1995","journal-title":"Int J Cardiol"},{"key":"e_1_2_7_27_2","first-page":"933","article-title":"Recurrence of dilated cardiomyopathy after reintroduction of a tricyclic antidepressant","volume":"99","author":"Briec F","year":"2006","journal-title":"Arch Mal Coeur Vaiss"},{"issue":"3","key":"e_1_2_7_28_2","doi-asserted-by":"crossref","first-page":"439S","DOI":"10.1111\/j.1365-2125.1983.tb02135.x","article-title":"Cardiac effects of antidepressant drugs. A comparison of the tricyclic antidepressants and fluvoxamine","volume":"15","author":"Roos JC","year":"1983","journal-title":"Br J Clin Pharmacol"},{"key":"e_1_2_7_29_2","first-page":"835","article-title":"Cardiac side effects of anti\u2010HIV agents","volume":"93","author":"Monsuez JJ","year":"2000","journal-title":"Arch Mal Coeur Vaiss"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200212053472320"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1086\/377609"},{"issue":"2","key":"e_1_2_7_32_2","doi-asserted-by":"crossref","first-page":"M73","DOI":"10.1177\/135965350501002S08","article-title":"Mitochondrial studies in HAART\u2010related lipodystrophy: from experimental hypothesis to clinical findings","volume":"10","author":"Miro O","year":"2005","journal-title":"Antivir Ther"},{"key":"e_1_2_7_33_2","first-page":"515","article-title":"Congestive cardiomyopathy in addition to clobenzorex, an anorexigenic drug","volume":"79","author":"Cornaert P","year":"1986","journal-title":"Arch Mal Coeur Vaiss"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199608293350901"},{"key":"e_1_2_7_35_2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1472-6904-2-6","article-title":"Appetite suppressants and valvular heart disease: a systematic review","volume":"2","author":"Weissman NJ","year":"2002","journal-title":"BMC Clin Pharmacol"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/clc.4960121211"},{"key":"e_1_2_7_37_2","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1200\/JCO.1998.16.5.1820","article-title":"Multicenter phase II trial of interleukin\u20102, interferon\u2010alpha, and 13\u2010cis\u2010retinoic acid in patients with metastatic renal cell carcinoma","volume":"16","author":"Stadler WM","year":"1998","journal-title":"J Clin Oncol"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-007-0333-3"},{"key":"e_1_2_7_39_2","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1177\/0269881106059696","article-title":"Cardiomyopathy after long\u2010term treatment with lithium: more than a coincidence?","volume":"20","author":"Aichhorn W","year":"2006","journal-title":"J Psychopharmacol"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.322.7296.1207"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2125.2009.03596.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2125.2009.03596.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T11:43:40Z","timestamp":1697456620000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2125.2009.03596.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,10]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["10.1111\/j.1365-2125.2009.03596.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2125.2009.03596.x","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,10]]}}}